Find out how we're leveraging AI to empower you to accelerate your science
Signals Research Suite™
Science is getting more complex. Simplify it with Signals Research Suite.
Make your innovations a reality with the first unified, cloud-native SaaS R&D platform that streamlines scientific complexity and promotes collaboration

Introduction to Signals Research Suite
The Signal Research Suite is an end-to-end R&D workflow solution providing data capture & collaboration, data processing, and data-driven analytics.

Accelerate Drug Discovery with Signals Research Suite
Experience the power of fast, flexible Drug Discovery software with Signals Research Suite to accelerate the development of new therapeutic modalities.
Signals Connect
Join us for this ongoing Signals Connect community series and learn how you can go beyond and get more out of your data using Revvity Signals Research Suite. Gain critical insights to accelerate your R&D discoveries.
Signals Research Suite
Discover how our platform acts as the catalyst for unprecedented discoveries, bringing researchers together on a global scale. Plus, optimize your synthesis or formulation process to meet your customers’ unmet needs and decrease cost and time to market.
Signals Research Suite has given Cogent Biosciences the kind of data analytics capabilities that were once the sole domain of big pharma companies with deep pockets and extensive IT departments.
Small Molecule Drug Discovery |
||
---|---|---|
Capabilities |
Description |
Benefits |
Compound Synthesis |
Streamlines the process of designing, planning and documenting chemical reactions.
|
|
Compound Analysis |
Researchers can efficiently make test requests, evaluate and interpret experimental data related to chemical compounds. |
|
Compound Registration |
Enables researchers to efficiently input, manage, and analyze chemical compound data through.
|
|
Empowers researchers to efficiently discover and evaluate potential drug candidates through:
|
|
|
in vitro analysis |
Developing assays to measure cell activity, processing assay data, visualizing assay results, and analyzing assays using High Content Screening (HCS) and Surface Plasmon Resonance (SPR) |
|
Lead Optimization |
Self-service analytics and visualization tools to refine promising drug candidates to enhance drug efficacy, safety, and pharmacokinetics properties.
|
|
Efficacy and Toxicology Studies |
Evaluate biological effects and potential toxicities in animal models through comprehensive data analysis and streamlined reporting workflows |
Predict treatment outcomes and identify potential adverse events at the preclinical stage, thereby reducing risks and enabling the optimization of the drug candidate’s therapeutic profile before clinical trials |
Pharmacokinetics and Pharmacodynamics |
Analyze and model PK/PD profiles to assess how a drug behaves in biological systems |
Gain critical insights empowered by Spotfire® into drug safety, ADME and optimal dosing, helping to optimize clinical trial designs and maximize the likelihood of success in late-stage development. |
Biomarker Discovery |
Identification and validation of biomarkers to measure effects of drug candidates |
|
Related Products

SignalsNotebook
The premier cloud-based electronic lab notebook for biologists and chemists to collaborate, capture, organize, share, and explore data.
Learn More
SignalsSynergy
Enhancing collaboration and information exchange between Sponsors and CROs.
Learn MoreScitara DLX
Streamline workflows with Revvity Signals and Scitara DLX. Enable rapid integration, unifying lab ecosystems for improved productivity.
Learn MoreLead Discovery Premium
Analyze and visualize chemical structure & biological sequence SAR data. Compare and score segment leads based on multi-parametric optimization.
Learn MoreRelated Events & Webinars
Resources
Signals Research Suite is ideally suited to handle research use cases involving earlier stage in-vitro assays, later stage in-vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetic studies, stage animal efficacy and safety studies.
Frequently Asked Questions (FAQs)
In what ways does the Signals Research Suite support the development of new drug modalities?
Signals Research suite is designed to handle the complexities associated with developing new drug modalities, such as protein degraders, RNA therapeutics, antibody-drug conjugates (ADCs), next-generation peptides, and gene therapies. It facilitates laboratory workflows, allowing the capture and analysis of diverse data types required for these advanced therapeutics. By providing tools for assay development, hit identification, and lead optimization, the suite accelerates the drug discovery process for these novel therapeutics.